Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT.

Haywood LJ, Davis BR, Piller LB, Simpson LM, Ghosh A, Einhorn PT, Ford CE, Probstfield JL, Soliman EZ, Wright JT Jr; ALLHAT Collaborative Research Group.

J Natl Med Assoc. 2018 Aug;110(4):343-351. doi: 10.1016/j.jnma.2017.07.003. Epub 2017 Jul 24.

2.

Quantitating Heart Damage: Part of the Story.

Haywood LJ.

Am J Med Sci. 2018 Jun;355(6):521-522. doi: 10.1016/j.amjms.2018.03.016. Epub 2018 Mar 27. No abstract available.

PMID:
29891033
3.

Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Dewland TA, Soliman EZ, Yamal JM, Davis BR, Alonso A, Albert CM, Simpson LM, Haywood LJ, Marcus GM.

Circ Arrhythm Electrophysiol. 2017 Dec;10(12). pii: e005463. doi: 10.1161/CIRCEP.117.005463.

4.

Influence of Prevalent and Incident Atrial Fibrillation on Post-Trial Major Events in ALLHAT.

Haywood LJ, Davis BR, Piller LB, Cushman WC, Cutler JA, Ford CE, Simpson LM, Ghosh A, Soliman EZ, Wright JT Jr; ALLHAT Collaborative Research Group.

J Natl Med Assoc. 2017 Autumn;109(3):172-181. doi: 10.1016/j.jnma.2017.02.005. Epub 2017 Mar 18.

5.

Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease.

Dewland TA, Soliman EZ, Davis BR, Magnani JW, Yamal JM, Piller LB, Haywood LJ, Alonso A, Albert CM, Marcus GM; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group.

JAMA Intern Med. 2016 Aug 1;176(8):1085-92. doi: 10.1001/jamainternmed.2016.2502.

PMID:
27367818
6.

Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]).

Alderman MH, Davis BR, Piller LB, Ford CE, Baraniuk MS, Pressel SL, Assadi MA, Einhorn PT, Haywood LJ, Ilamathi E, Oparil S, Retta TM; ALLHAT Collaborative Research Group.

Am J Cardiol. 2016 Jan 1;117(1):105-15. doi: 10.1016/j.amjcard.2015.10.012. Epub 2015 Oct 19.

7.

Abnormal Origin of the Right Pulmonary Artery From Ascending Aorta (Hemitruncus Arteriosus).

Haywood LJ, Chakryan Y, Kim D, Boltzer T, Rivas G, Shavelle D.

J Investig Med High Impact Case Rep. 2014 Jul 27;2(3):2324709614536139. doi: 10.1177/2324709614536139. eCollection 2014 Jul-Sep.

8.

Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex.

Oparil S, Davis BR, Cushman WC, Ford CE, Furberg CD, Habib GB, Haywood LJ, Margolis K, Probstfield JL, Whelton PK, Wright JT Jr; ALLHAT Collaborative Research Group.

Hypertension. 2013 May;61(5):977-86. doi: 10.1161/HYPERTENSIONAHA.111.00213. Epub 2013 Mar 25.

9.

Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.

Rahman M, Ford CE, Cutler JA, Davis BR, Piller LB, Whelton PK, Wright JT Jr, Barzilay JI, Brown CD, Colon PJ Sr, Fine LJ, Grimm RH Jr, Gupta AK, Baimbridge C, Haywood LJ, Henriquez MA, Ilamaythi E, Oparil S, Preston R; ALLHAT Collaborative Research Group.

Clin J Am Soc Nephrol. 2012 Jun;7(6):989-1002. doi: 10.2215/CJN.07800811. Epub 2012 Apr 5.

10.

Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Cushman WC, Davis BR, Pressel SL, Cutler JA, Einhorn PT, Ford CE, Oparil S, Probstfield JL, Whelton PK, Wright JT Jr, Alderman MH, Basile JN, Black HR, Grimm RH Jr, Hamilton BP, Haywood LJ, Ong ST, Piller LB, Simpson LM, Stanford C, Weiss RJ; ALLHAT Collaborative Research Group.

J Clin Hypertens (Greenwich). 2012 Jan;14(1):20-31. doi: 10.1111/j.1751-7176.2011.00568.x. Epub 2011 Dec 9.

11.

Racial/ethnic differences in the prevalence of atrial fibrillation among older adults--a cross-sectional study.

Haywood LJ.

J Natl Med Assoc. 2011 Feb;103(2):180-1. No abstract available.

PMID:
21443074
12.

Serious ups and downs.

Chen SF, Yabumoto K, Haywood LJ.

Am J Med. 2010 Dec;123(12):1094-6. doi: 10.1016/j.amjmed.2010.07.003. Epub 2010 Oct 15. No abstract available.

PMID:
20951367
13.

Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Haywood LJ, Ford CE, Crow RS, Davis BR, Massie BM, Einhorn PT, Williard A; ALLHAT Collaborative Research Group.

J Am Coll Cardiol. 2009 Nov 24;54(22):2023-31. doi: 10.1016/j.jacc.2009.08.020.

14.

ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.

Wright JT Jr, Probstfield JL, Cushman WC, Pressel SL, Cutler JA, Davis BR, Einhorn PT, Rahman M, Whelton PK, Ford CE, Haywood LJ, Margolis KL, Oparil S, Black HR, Alderman MH; ALLHAT Collaborative Research Group.

Arch Intern Med. 2009 May 11;169(9):832-42. doi: 10.1001/archinternmed.2009.60.

15.

Cardiovascular function and dysfunction in sickle cell anemia.

Haywood LJ.

J Natl Med Assoc. 2009 Jan;101(1):24-30. Review.

PMID:
19245069
16.

Clinical assessment of the risk for sudden cardiac death in patients with sickle cell anemia.

Fontaine JM, Ofili EO, Adenaike MB, VanDecker W, Haywood LJ.

J Natl Med Assoc. 2008 Apr;100(4):360-8.

PMID:
18481474
17.

Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Wright JT Jr, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, Basile JN, Black HR, Dart R, Gupta AK, Hamilton BP, Einhorn PT, Haywood LJ, Jafri SZ, Louis GT, Whelton PK, Scott CL, Simmons DL, Stanford C, Davis BR.

Arch Intern Med. 2008 Jan 28;168(2):207-17. doi: 10.1001/archinternmed.2007.66.

18.

Acute myocardial infarction with normal coronary arteries in a patient with Hodgkin's disease.

Haywood LJ.

Tex Heart Inst J. 2007;34(1):135. No abstract available.

19.

Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, Alderman MH, Atlas SA, Basile JN, Cuyjet AB, Dart R, Felicetta JV, Grimm RH, Haywood LJ, Jafri SZ, Proschan MA, Thadani U, Whelton PK, Wright JT; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.

Hypertension. 2006 Sep;48(3):374-84. Epub 2006 Jul 24.

PMID:
16864749
20.

Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial.

Bush D, Martin LW, Leman R, Chandler M, Haywood LJ; NHLBI AFFIRM Investigators.

J Natl Med Assoc. 2006 Mar;98(3):330-9.

21.
22.

Left bundle branch block in acute myocardial infarction: benign or malignant?

Haywood LJ.

J Am Coll Cardiol. 2005 Jul 5;46(1):39-41. No abstract available. Erratum in: J Am Coll Cardiol. 2005 Sep 6;46(5):936.

23.

Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.

Sherman DG, Kim SG, Boop BS, Corley SD, Dimarco JP, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim MH, Nasco E, Waldo AL; National Heart, Lung, and Blood Institute AFFIRM Investigators.

Arch Intern Med. 2005 May 23;165(10):1185-91.

PMID:
15911734
24.

Ventricular diastolic function study has shortcomings.

Haywood LJ.

J Natl Med Assoc. 2005 Apr;97(4):583. No abstract available.

25.

Bone marrow embolism in sickle cell disease: a review.

Dang NC, Johnson C, Eslami-Farsani M, Haywood LJ.

Am J Hematol. 2005 May;79(1):61-7. Review.

26.

Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.

Wright JT Jr, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, Haywood LJ, Leenen FH, Margolis KL, Papademetriou V, Probstfield JL, Whelton PK, Habib GB; ALLHAT Collaborative Research Group.

JAMA. 2005 Apr 6;293(13):1595-608.

PMID:
15811979
27.

Atrial fibrillation in a multiethnic inpatient population of a large public hospital.

Dang D, Patel R, Haywood LJ.

J Natl Med Assoc. 2004 Nov;96(11):1438-44.

28.

A review of atrial fibrillation.

Dang D, Arimie R, Haywood LJ.

J Natl Med Assoc. 2002 Dec;94(12):1036-48. Review.

29.

Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone.

Piller LB, Davis BR, Cutler JA, Cushman WC, Wright JT Jr, Williamson JD, Leenen FH, Einhorn PT, Randall OS, Golden JS, Haywood LJ; The ALLHAT Collaborative Research Group .

Curr Control Trials Cardiovasc Med. 2002 Nov 14;3(1):10.

30.

Access to Care for Elderly Persons.

Haywood LJ.

Am J Geriatr Cardiol. 1997 Nov;6(6):32-37.

PMID:
11416435
31.

Early efforts of blacks in the fight against heart disease and stroke.

Haywood LJ.

J Natl Med Assoc. 1999 Dec;91(12):669-75.

32.

Social class and recovery from myocardial infarction.

Haywood LJ.

Ann Intern Med. 1998 Apr 15;128(8):695-6. No abstract available.

PMID:
9537950
33.

Predictive value of prior Rose angina for myocardial infarction confirmation after emergency admissions.

Haywood LJ, Faucett C, deGuzman M, Ell K, Norris S, Butts E.

J Natl Med Assoc. 1998 Apr;90(4):241-52. Erratum in: J Natl Med Assoc 1998 Aug;90(8):453.

34.

Tumor necrosis factor alpha.

Haywood LJ.

J Natl Med Assoc. 1998 Mar;90(3):129. No abstract available.

35.

Early radionuclide scans for risk assessment in suspected acute myocardial infarction.

Norris SL, Haywood LJ, Sobel E, Hung GL, deGuzman M, Siegel M.

J Natl Med Assoc. 1997 Dec;89(12):791-800.

36.

Recurrent myocardial infarction with patent coronary arteries.

Haywood LJ, Khan AH, Bornheimer J, Finck E, Tatter D.

J Natl Med Assoc. 1997 Jun;89(6):415-20. Review.

37.

The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction.

Toth K, Bogar L, Juricskay I, Keltai M, Yusuf S, Haywood LJ, Meiselman HJ.

Clin Hemorheol Microcirc. 1997 Mar-Apr;17(2):117-25.

PMID:
9255435
38.

Under use of coronary angiography: application of a clinical method.

Laouri M, Kravitz RL, Bernstein SJ, French WJ, Leake B, Borowsky SJ, Haywood LJ, Brook RH.

Int J Qual Health Care. 1997 Feb;9(1):15-22.

PMID:
9154487
39.

Congestive heart failure revisited: new concepts in treatment.

Haywood LJ.

J Natl Med Assoc. 1996 Aug;88(8):526-31.

40.

Method for assessing cardiac function using magnetic resonance imaging.

Soldo SJ, Haywood LJ, Norris SL, Gober JR, Colletti PM, Terk MR.

Biomed Instrum Technol. 1996 Jul-Aug;30(4):359-63.

PMID:
8839992
41.

The application of magnetic resonance techniques to the evaluation of the patient with sickle-cell disease.

Terk MR, Zee CS, Colletti PM, Haywood LJ.

Biomed Instrum Technol. 1996 Jul-Aug;30(4):349-53. Review.

PMID:
8839990
42.

Myocardial infarction in sickle cell disease.

Martin CR, Johnson CS, Cobb C, Tatter D, Haywood LJ.

J Natl Med Assoc. 1996 Jul;88(7):428-32.

43.

Our ailing public hospitals.

Haywood LJ.

N Engl J Med. 1996 Feb 29;334(9):597. No abstract available.

PMID:
8569832
44.

Effect of physician specialty on use of necessary coronary angiography.

Borowsky SJ, Kravitz RL, Laouri M, Leake B, Partridge J, Kaushik V, Haywood LJ, Brook RH.

J Am Coll Cardiol. 1995 Nov 15;26(6):1484-91.

45.

Linus Pauling, PHD: remembering a presentation to the NMA.

Haywood LJ.

J Natl Med Assoc. 1995 Feb;87(2):97-8. No abstract available.

46.

Advancing the cause of academic minority physicians and scientists.

Haywood LJ.

J Assoc Acad Minor Phys. 1995;6(1):11-3.

PMID:
7858371
47.

Differential perceptions, behaviors, and motivations among African Americans, Latinos, and whites suspected of heart attacks in two hospital populations.

Ell K, Haywood LJ, deGuzman M, Sobel E, Norris S, Blumfield D, Ning JP, Butts E.

J Assoc Acad Minor Phys. 1995;6(2):60-9.

PMID:
7772934
48.

Guidelines for unstable angina--application to African Americans?

Haywood LJ.

J Natl Med Assoc. 1994 Sep;86(9):656-7. No abstract available.

49.

Task Force 1: The underserved.

Haywood LJ, Francis CK, Cregler LL, Freed MD, Skorton DJ.

J Am Coll Cardiol. 1994 Aug;24(2):282-90.

50.

Acute chest pain in African Americans: factors in the delay in seeking emergency care.

Ell K, Haywood LJ, Sobel E, deGuzman M, Blumfield D, Ning JP.

Am J Public Health. 1994 Jun;84(6):965-70.

Supplemental Content

Loading ...
Support Center